Detalles de la búsqueda
1.
Expression of HLA-DR by mesenchymal stromal cells in the platelet lysate era: an obsolete release criterion for MSCs?
J Transl Med;
22(1): 39, 2024 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38195462
2.
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease.
J Transl Med;
21(1): 837, 2023 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37990219
3.
A New Perspective for Bone Tissue Engineering: Human Mesenchymal Stromal Cells Well-Survive Cryopreservation on ß-TCP Scaffold and Show Increased Ability for Osteogenic Differentiation.
Int J Mol Sci;
23(3)2022 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35163348
4.
Correction: Realworld data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSCFFM in ruxolitinibrefractory acute graftversushost disease.
J Transl Med;
22(1): 566, 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38872104
5.
Fast enzymatic synthesis of n.c.a. 6-[18 F]fluorodopamine (FDA) from n.c.a. 6-[18 F]FDOPA and the fate of 6-FDOPA and 6-FDA in neuroblastoma and Caki-1 cells after their uptake.
J Labelled Comp Radiopharm;
62(8): 438-447, 2019 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31090094
6.
Clinical Use of Mesenchymal Stromal Cells in the Treatment of Acute Graft-versus-Host Disease.
Transfus Med Hemother;
46(1): 27-34, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31244579
7.
Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey.
Haematologica;
101(8): 985-94, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27175026
8.
In vitro migration and proliferation ("wound healing") potential of mesenchymal stromal cells generated from human CD271(+) bone marrow mononuclear cells.
J Transl Med;
13: 315, 2015 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-26407865
9.
Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression.
Haematologica;
98(10): 1609-16, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23975178
10.
Validation of an ICH Q2 Compliant Flow Cytometry-Based Assay for the Assessment of the Inhibitory Potential of Mesenchymal Stromal Cells on T Cell Proliferation.
Cells;
12(6)2023 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980191
11.
Influence of dichloroacetate (DCA) on lactate production and oxygen consumption in neuroblastoma cells: is DCA a suitable drug for neuroblastoma therapy?
Cell Physiol Biochem;
29(3-4): 373-80, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22508045
12.
Mesenchymal stromal cells derived from CD271(+) bone marrow mononuclear cells exert potent allosuppressive properties.
Cytotherapy;
13(10): 1193-204, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21905954
13.
H(2)O(2)-mediated cytotoxicity of pharmacologic ascorbate concentrations to neuroblastoma cells: potential role of lactate and ferritin.
Cell Physiol Biochem;
25(6): 767-74, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20511723
14.
Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation.
Haematologica;
95(9): 1579-86, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20378565
15.
CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties.
Haematologica;
95(4): 651-9, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20179086
16.
The Phenotype and Functional Activity of Mesenchymal Stromal Cells in Pediatric Patients with Non-Malignant Hematological Diseases.
Cells;
9(2)2020 02 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32059574
17.
Molecular signature of human bone marrow-derived mesenchymal stromal cell subsets.
Sci Rep;
9(1): 1774, 2019 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30742027
18.
Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients.
Cells;
8(12)2019 12 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31817480
19.
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM).
Bone Marrow Transplant;
53(7): 852-862, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29379171
20.
Pitfalls in detection of contaminating neuroblastoma cells by tyrosine hydroxylase RT-PCR due to catecholamine-producing hematopoietic cells.
Anticancer Res;
26(3A): 2075-80, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16827147